Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

american pharmacists association licensure examination

Beoordeling
-
Verkocht
-
Pagina's
342
Cijfer
A+
Geüpload op
13-04-2025
Geschreven in
2024/2025

american pharmacists association licensure examination

Instelling
Vak

Voorbeeld van de inhoud

APHA NAPLEX (ACTUAL 2025/2026) QUESTIONS AND
VERIFIED ANSWERS




When 2 anti-infective therapies together produce a greater
effect than the effects of each used alone, this phenomenon is
termed


A. commensalism
B. synergy
C. antagonism
D. additive
E. interacting ----Answers----B. Synergy


Analysis of the cerebrospinal fluid may give valuable clues to
the identity of the pathogen in meningitis. Given the following
results, what would be indicative of a bacterial infx?


I. increased WBCs
II. increased glucose
III. increased protein


A. I only
B. II only
C. I and III only

,D. II and III only
E. all of the above ----Answers----C. Bacterial meningitis infx
show an increase in WBC and proteins in the CSF. Glucose is
decreased


Empiric therapy for meningitis for pts up to 1mo of age
includes


A. vanco and ampicillin
B. aminoglycoside and ampicillin
C. ceftriaxone and vancomycin
D. vanco and aminoglycosides
E. ampicillin and ceftriaxone ----Answers----B. the regimen
covers the most likely organisms for meningitis in this age
group: Stept agalactiae, E.coli, Listeria monocytogenes
(ampicillin), and Klebsiella species. Ampicillin and cefotaxime
would be another appropriate choice for empiric therapy in pts
up to 1mo of age


CF is a 65yo male diagnosed with endocarditis. Blood cultures
reveal a highly sensitive strain of Streptococcus. Which of the
following is most appropriate if CF has an anaphylactoid
penicillin allergy?


A. vancomycin
B. gentamicin
C. ceftriaxone and gentamicin

,D. meropenem
E. rifampin and gentamicin ----Answers----A. Vancomycin is
appropriate for penicillin allergic pts with endocarditis caused
by Strept species. Other regimens for strep include penicillin
or ceftriaxone (w/ or w/o gent), which has a potential for
cross-linking reactivity in pts w/ penicillin allergies


Pts presenting with acute bronchitis without risk factors
should be treated empirically with


A. supportive care
B. clarithromcyin
C. cefuroxime
D. ciprofloxacin
E. erythromycin ----Answers----A. B/c half of bronchitis infx
are caused by viral etiology, antibacterial therapy for low-risk
pts should not be attempted unless severe presentation


The most common organisms associated with CAP in adults
treated as outpts are


A. pseudomonas aeruginosa, mycoplasma pneumo, and h. flu
B. strept pneumo, h. flu. and klebsiella pneumo
C. mycoplasma pneumo, strept pneumo, h. flu, and kleb
pneumo
D. mycoplasma pneumo, strept pneumo, h. flu, and
chlamydophila pneumo

, E. mycoplasma pneumo, strept pneumo, h. flu, and
pseudomonas aeruginosa ----Answers----D. Pseudomonas
aeruginosa is more likely in pts with risk factors for multidrug
resistant bacteria such as late-onset HAP or VAP. Kleb
pneumoniae is also not commonly associated with CAP.


Which of the following is an appropriate regimen for a pt w/
early-onset HAP w/o risk factors for MDR pathogens?


A. doxycycline
B. azithromycin
C. unasyn
D. cipro and vanco
E. cefepime, cipro, and vanco ----Answers----C. Empiric
therapy for early-onset HAP w/o risk factors for MDR
resistant pathogens is as follows: ceftriaxone, a
fluoroquinolone, unasyn, or ertapenem. Doxycycline or
azithromycin is appropriate for outpatient treatment of CAP.
Cefepime, cipro and vanco in combination are appropriate for
late-onset HAP or pts w/ risk factors for MDR.


Initial treatment of active TB infections in which no resistant
strains of mycobacterium tuberculosis are suspected should
include


A. rifabutin and pyrazinamide
B. rifampin and pyrazinamide
C. ethambutol, rifampin, isoniazid, and pyrazinamide

Geschreven voor

Vak

Documentinformatie

Geüpload op
13 april 2025
Aantal pagina's
342
Geschreven in
2024/2025
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$8.49
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper
Seller avatar
SmartStudySolution

Maak kennis met de verkoper

Seller avatar
SmartStudySolution Bloomsburg University Of Pennsylvania
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
4
Lid sinds
2 jaar
Aantal volgers
0
Documenten
248
Laatst verkocht
2 maanden geleden
Smart Study | Best Test Banks for Success

Welcome to Smart Study, your go-to destination for high-quality test banks, study guides, and exam solutions. Whether you're preparing for a tough exam or looking for reliable study resources, we've got you covered! ✅ Verified & High-Quality Content ✅ Comprehensive Test Banks & Solutions ✅ Instant Download for Quick Access ✅ Designed to Help You Succeed Study smarter, not harder! Get the best test banks today and stay 100% exam ready!

Lees meer Lees minder
0.0

0 beoordelingen

5
0
4
0
3
0
2
0
1
0

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen